series-a
Stage
2023
Founded
3
Investors
About
Citryll is a biotechnology company developing novel therapeutics for autoimmune and inflammatory diseases. Their lead program, CIT-001, targets citrullinated proteins to reduce inflammation and tissue damage.
Explore Citryll's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.